Cart
sales@molnova.com
VUF 10166
CAS No. 155584-74-0
VUF 10166 ( —— )
Catalog No. M17335 CAS No. 155584-74-0
VUF10166 is a novel, potent and competitive antagonist for 5-HT3A receptor with Ki of 0.04 nM, its affinity at 5-HT3AB receptor is significantly lower.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 37 | In Stock |
|
| 10MG | 59 | In Stock |
|
| 25MG | 112 | In Stock |
|
| 100MG | 299 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVUF 10166
-
NoteResearch use only, not for human use.
-
Brief DescriptionVUF10166 is a novel, potent and competitive antagonist for 5-HT3A receptor with Ki of 0.04 nM, its affinity at 5-HT3AB receptor is significantly lower.
-
DescriptionVUF10166 is a novel, potent and competitive antagonist for 5-HT3A receptor with Ki of 0.04 nM, its affinity at 5-HT3AB receptor is significantly lower.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
Recptor5-HT3A; 5-HT3AB
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number155584-74-0
-
Formula Weight262.74
-
Molecular FormulaC13H15ClN4
-
Purity98%
-
Solubility——
-
SMILESCN1CCN(CC1)C1=NC2=CC=CC=C2N=C1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Thompson AJ, et al. J Pharmacol Exp Ther, 2012, 341(2), 350-9.
molnova catalog
related products
-
Dacomitinib
Dacomitinib (PF-00299804, PF-299804) is a potent, irreversible, orally active pan-ErbB receptor tyrosine kinase inhibitor with IC50 of 6, 45.7 and 73.7 for EGFR, ERBB2 and ERBB4, respectively.
-
WHI-P154
WHI-P154 is a potent JAK3 inhibitor with IC50 of 1.8 μM, no activity against JAK1 or JAK2, also inhibits EGFR, Src, Abl, VEGFR and MAPK, prevents Stat3, but not Stat5 phosphorylation.
-
XL-647
XL-647 (Tesevatinib, EXEL-7647, KD-019) is a novel spectrum-selective kinase inhibitor that potently inhibits the EGFR, ErbB2, KDR and EphB4 with IC50 of 0.3, 16, 1.5 and 1.4 nM, respectively.
